Skip to main content
High RiskFDAfda-F-2117-2019UNDECLARED ALLERGEN

Peanut Butter bread packages contain two bread pastries filled with peanut butter filling. They are packaged together in a clear plastic...

Category
Units Affected
2
Recall Date
August 12, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2117-2019.

Label declares flour but does not declare wheat. Product contains Non-Dairy Cream but label does not declare this sub-ingredient Soy Lecithin.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2117-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Olive Bakery or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2117-2019.

Olive Bakery

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Olive Bakery Recall FAQ

Olive Bakery is the subject of a dairy safety report: Peanut Butter bread packages contain two bread pastries filled with peanut butter filling. They are packaged together in a clear plastic.... The notice was published on August 12, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 2 units are potentially affected.